Tacey X. Viegas - Concepedia

Author

Tacey X. Viegas

BioCryst Pharmaceuticals (United States)

Also Known As

T.X. Viegas, Tacey X Viegas, Tacey X. Viegas, Viegas, Tacey X.

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

BioCryst Pharmaceuticals (United States)Mirna Therapeutics (United States)University of Alabama at Birmingham University of Padua Icahn School of Medicine at Mount Sinai

About

Tacey X. Viegas is an author at BioCryst Pharmaceuticals (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	264
2	Engineering	2	2	90
3	Biomolecular Engineering	1	1	80
4	Cell Biology	1	1	80
5	Chemical Engineering	1	1	10

Tacey X. Viegas

Publications

926

Citations

H-Index

Page 1

	Year	Citations
Polyoxazoline: Chemistry, Properties, and Applications in Drug Delivery Tacey X. Viegas, Michael D. Bentley, J. Milton Harris, Bioconjugate Chemistry	2011	418
Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson’s disease – Proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications Randall W. Moreadith, Tacey X. Viegas, Michael D. Bentley, European Polymer Journal Neurodegenerative DiseasesPharmaceutical SciencePolymer-drug ConjugateMedicineMultiple Therapeutic Indications	2016	171
Selective conjugation of poly(2-ethyl 2-oxazoline) to granulocyte colony stimulating factor Anna Mero, Zhihao Fang, Gianfranco Pasut, Journal of Controlled Release Selective ConjugationEngineeringPolymer-drug ConjugateCell BiologyPolymer Chemistry	2012	80
Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit Karen L. Eskow Jaunarajs, David G. Standaert, Tacey X. Viegas, Movement Disorders	2013	67
Tuning drug release from polyoxazoline-drug conjugates J. Milton Harris, Michael D. Bentley, Randall W. Moreadith, European Polymer Journal Pharmaceutical SciencePolymer-drug ConjugateMedicineDrug ReleasePharmacology	2019	49
<scp>Once‐Weekly</scp> Subcutaneous Delivery of <scp>Polymer‐Linked</scp> Rotigotine (<scp>SER</scp>‐214) Provides Continuous Plasma Levels in Parkinson's Disease Patients C. Warren Olanow, David G. Standaert, Karl Kieburtz, Movement Disorders	2020	47
Pharmacokinetics and Pharmacodynamics of Peldesine (BCX‐34), a Purine Nucleoside Phosphorylase Inhibitor, following Single and Multiple Oral Doses in Healthy Volunteers Tacey X. Viegas, George Omura, R Stoltz, The Journal of Clinical Pharmacology	2000	40
Relative bioavailability of danazol in dogs from liquid-filled hard gelatin capsules LuAnn Erlich, Danny Yu, David A. Pallister, International Journal of Pharmaceutics Pharmaceutical ScienceMedicineVeterinary ScienceToxicologyRelative Bioavailability	1999	34
Osmotic behavior of poloxamer 407 and other non-ionic surfactants in aqueous solutions Tacey X. Viegas, Raymond L. Henry International Journal of Pharmaceutics Chemical EngineeringEngineeringOsmotic BehaviorSurfactantsWater Purification	1998	10
Intrinsic Drug Dissolution Testing Using the Stationary Disk System Tacey X. Viegas, Roxanne U. Curatella, Lise L. VanWinkle Dissolution Technologies MedicineDrug PurityPharmaceutical TechnologyDrug TestAnalytical Chemistry	2001	10

Page 1